Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Senior Editor, Pharma Insights
UK
+17 year(s) experience
Scrip
Sweden-based Kancera hopes to advance its investigative anti-inflammation drug in a Phase II trial to treat severe COVID-19 patients and then build its applications from there.
Topic Coronavirus Clinical Trials
Scrip
Adequate funding and joined-up global cooperation are two top priorities needed to combat COVID-19, a panel of pharma executives told this year’s BIO-Europe Spring.
Topic Coronavirus
Scrip
Ruud Dobber oversees AstraZeneca’s biopharmaceuticals division, which generates some 40% of group total revenues. He tells Scrip to “Watch this space.”
Scrip
VC Firm Sofinnova’s Chair Papiernik Speaks After New Fund Launch The chairman of Sofinnova Partners told Scrip his newly launched biotech start-up fund aims to profit from Europe’s top science, relatively realistic asset prices, and geopolitical position between the US and China.
Scrip
Vaccine maker Sanofi Pasteur and managed care group Kaiser Permanente have joined forces in an observational trial using electronic medical records from 1.6 million people to highlight the benefits of integrated big data.
Scrip
The managing director for Sanofi in the UK says clinical trials there will become less likely in future if access to innovative drugs doesn't improve, causing comparative standards of care to deteriorate.
Scrip
Flush with IPO funding, AI-focused healthcare technology group Sensyne Health will now ready additional products and find three more NHS trust partnerships. CEO Lord Drayson spoke to Scrip.
Topic Research Business strategies
Scrip
Successfully piecing together the agreed life sciences sector deal calls for the UK to embrace high-risk innovation.
Topic Brexit
Scrip
Vasant Narasimhan, who is replacing Joseph Jimenez as Novartis' CEO next year, is an advocate of automation and artificial intelligence in future drug discovery.
Topic Business strategies
Scrip
Ireland-based Jazz Pharma is extending its shift away from specialty pharma with an option-based deal with ImmunoGen involving three antibody-drug conjugate programs.
Topic Business strategies
Scrip
UK-based Destiny Pharma hopes its planned IPO will attract investor demand.
Topic Clinical trials
Scrip
Datamonitor Healthcare's latest sector analysis indicates that the pharma industry's 10 biggest companies.
Scrip
Flemming Ornskov says FDA approval of long-lasting ADHD therapy Mydayis.
Scrip
Roche CEO Severin Schwan says analysts at ASCO missed a key APHINITY message on Herceptin follow-on Perjeta.
Topic Research
Pink Sheet
Biogen's chief medical officer says iPhone technology should in future be used for early warning diagnosis of Alzheimer's Disease.
Topic Alzheimers
Scrip
28 Jul 2021
Scrip
27 Jul 2021
Scrip
23 Jul 2021
Scrip
16 Jul 2021
Scrip
15 Jul 2021
Scrip
13 Jul 2021
Scrip
07 Jul 2021
Scrip
06 Jul 2021
Scrip
02 Jul 2021
Scrip
30 Jun 2021
Scrip
29 Jun 2021
Scrip
24 Jun 2021
Scrip
23 Jun 2021
Scrip
22 Jun 2021
In Vivo
22 Jun 2021
